|
|
 |
|
Viewing report
|
|
|
|
Ambrilia Biopharma Inc. - Strategic SWOT Analysis Review
GlobalData, Aug 2011, Pages: 27
Ambrilia Biopharma Inc. - Strategic SWOT Analysis Review
Summary
Ambrilia Biopharma Inc. (Ambrilia) is a biotechnology company engaged in the discovery, development and commercialization of small molecules and peptides for the treatment of infectious diseases and cancer. The product pipeline of Ambrilia include: C2L Octreotide to treat acromegaly;Goserelin to treat hormone-sensitive prostate cancer; NGR-Delivery technology for cancer; Protease Inhibitors; Integrase Inhibitors; and Influenza M2 Proton Channel Inhibitors. Ambrilia was a public company but the Toronto Stock Exchange has delisted the common shares of Ambrilia as at the close of market on March 4, 2011 for failure to meet the continued listing requirements of the Toronto Stock Exchange. Ambrilia is headquartered at Verdun in Quebec, Canada.
Ambrilia Biopharma Inc. Key Recent Developments…
Apr 08, 2011: Ambrilia Will Seek Permission To Terminate CCAA Protection And File For Bankruptcy
Feb 04, 2011: Toronto Stock Exchange To Delist Ambrilia's Common Shares
Jan 27, 2011: Ambrilia Biopharma Obtains Seventh Extension Of CCAA Stay
Jul 07, 2010: Ambrilia Provides Bi-Weekly Update On Default Status
Jun 29, 2010: Ambrilia Appoints Faraj Nakhleh To Board
GlobalData’s Ambrilia Biopharma Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
|
|
|
|
